LUNG CANCER METASTATIC
Clinical trials for LUNG CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER METASTATIC trials appear
Sign up with your email to follow new studies for LUNG CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cholesterol drug boost immunotherapy in lung cancer?
Disease control TerminatedThis study tested whether adding evolocumab (a cholesterol-lowering drug) to standard immunotherapy (nivolumab and ipilimumab) is safe and helps the immune system fight advanced non-small cell lung cancer. It included 19 people with newly diagnosed metastatic lung cancer who had …
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: Eziafa Oduah, MD, PhD, MPH • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Lung cancer combo trial halted early – what we know
Disease control TerminatedThis study tested a new pill (SLC-391) combined with an immunotherapy drug (pembrolizumab) in 36 adults with advanced non-small cell lung cancer that had spread. The goal was to find a safe dose and see if the combination could shrink tumors. The trial was terminated early, so re…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: SignalChem Lifesciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for brain metastases? study tests pembrolizumab combo
Disease control TerminatedThis study looked at whether adding the drug pembrolizumab to chemotherapy could help people with a type of lung cancer that has spread to the brain but isn't causing symptoms. The goal was to control the cancer in the brain and body while keeping quality of life. Only 3 people t…
Matched conditions: LUNG CANCER METASTATIC
Phase: PHASE2 • Sponsor: John L. Villano, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC